Information Resources for Medication-Assisted Treatment (MAT)
Outlines federal drug policy priorities and promotes short and long-term solutions to reduce drug use, overdose, and other related harms in the U.S. Priorities include: expanding access to medication for opioid use disorder and other evidence-based treatment; advancing racial equity in drug policy; enhancing harm reduction efforts; supporting youth substance use prevention; reducing the supply of illicit substances; advancing recovery-ready workplaces; and expanding addiction workforce and access to recovery support services. Includes strategies to address substance use issues in rural and underserved communities.
Provides information and resources for healthcare and social service organization leaders and providers to improve care coordination and access to services for women with opioid use disorder (OUD) in programs supported by the Health Resources and Services Administration (HRSA), such as health centers, Rural Health Clinics (RHCs), Ryan White HIV/AIDS clinics, and home visiting programs, as well as in other care settings. Focuses on shifting the culture around addiction and treatment, engaging women with OUD in care, and creating and maintaining partnerships that support care coordination for women with OUD. Offers self-assessment tools and metrics to help users monitor and evaluate care coordination in their organizations.
Offers a dataset with information on Medicare-enrolled Opioid Treatment Program (OTP) providers that is updated monthly. Contains the name, National Provider Identifier (NPI), address, phone number, and the effective enrollment date for each provider. Includes resources for understanding and using the data.
Offers evidence-based opioid overdose prevention practices for community leaders, local and regional organizers, nonprofit groups, law enforcement, public health and other members of the public. Provides summaries of effective strategies to prevent opioid overdose and the context in which they are most effective. Discusses targeted naloxone distribution, including Good Samaritan laws, syringe services programs, criminal justice settings, and medication-assisted treatment (MAT) and initiating MAT in emergency departments. Summarizes the major research on each practice and offers examples of organizations that have successfully used the strategies to reduce the risk of overdose.
Provides information, resources, and eligibility criteria to obtain free training to provide medications for opioid use disorder (MOUD) for eligible clinicians working to address the opioid epidemic.
Collaborates with tribal stakeholders across the U.S. to address issues related to the treatment of chronic pain and the use of heroin and prescription opioids among tribal populations. Works to promote appropriate and effective pain management, reduce opioid overdose deaths, and improve access to culturally appropriate substance use prevention, treatment, and recovery services for American Indian and Alaska Native communities. Workgroup focus areas include prescriber support, treatment and recovery, harm reduction, program effectiveness metrics, technical assistance, and communications.
Describes a benefit that covers opioid use disorder (OUD) treatment services under Medicare Part B medical insurance. Enables the Centers for Medicare & Medicaid Services (CMS) to make bundled payments to certified opioid treatment programs (OTPs) for OUD treatment services for an episode of care provided to Medicare Part B beneficiaries. Covers the following services under the benefit: opioid agonist and antagonist medication-assisted treatment (MAT) medications approved by the U.S. Food and Drug Administration (FDA), naloxone and overdose education, substance use counseling, individual and group therapy, toxicology testing, intake activities, and periodic assessments.
Provides information on methadone, buprenorphine, and naltrexone and how they are used to provide medication-assisted treatment (MAT) for opioid use disorder (OUD). Covers the signs of an overdose and answers questions about each medication.
Shares the results of a survey of practitioners affiliated with Rural Communities Opioid Response Program (RCORP) grant sites throughout the U.S. to assess substance use disorder (SUD) stigma and treatment needs in rural areas. Includes various statistics on practitioner demographics, professional roles, work setting, medications for opioid use disorder (MOUD), stigma, and other practitioner beliefs and barriers.
Toolkit sharing field guidance, resources, and presentations to support clinical decisions about starting, continuing, or tapering opioid therapy, and other challenges related to safe opioid prescribing. Includes patient and provider education, clinical tools, and other resources.
Offers comprehensive information and resources on the use of prescription opioids, managing chronic pain, and opioid use disorder (OUD) for patients and providers, specifically for American Indian and Alaska Native (AI/AN) communities and Indian Health Service (IHS) providers. Includes online tools, technical assistance resources, guides, and training for patients and providers on topics such as opioid crisis data, opioid prevention, proper pain management, opioid prescribing/stewardship, culturally appropriate practices, maternal health, harm reduction, naloxone use, child health and wellness, medication-assisted treatment (MAT), tele-MAT, trauma-informed care, best practices, supportive services, wellness courts, and training opportunities. Resource is an initiative of the IHS Alcohol and Substance Abuse Branch (ASAB).
Highlights discussion and policy priorities from a August 2022 virtual roundtable meeting focused on increasing awareness and understanding of the barriers and challenges related to buprenorphine access in pharmacy settings the U.S. Includes specific observations and recommendations to improve buprenorphine access in pharmacy settings in rural areas.
Provides an overview of medications for opioid use disorder (MOUD) and medications for alcohol use disorder (AUD), as well as information on opioid treatment programs (OTPs). Describes current federal regulations and requirements for practitioners to prescribe MOUD. Includes information and training resources for healthcare providers, researchers, and patients.
Provides an overview of treatment options for veterans experiencing substance use issues. Includes information on different therapies, medications to reduce opioid and other substance use, intensive outpatient treatment, residential care, continuing care and relapse prevention, self-help groups, and more.
Describes the enterprise-wide initiatives currently supported by the Veterans Health Administration (VHA) Office of Rural Health. Shares the work of the U.S. Department of Veterans Affairs' (VA) national programs to provide healthcare services in VA hospitals and health systems to veterans residing in rural areas across the nation. Outlines programs to address primary care, specialty care, mental health, care coordination, workforce training and education, transportation, and more. Includes virtual training for providers on substance use disorder (SUD) treatment and recovery, as well as a pharmacy-based program to increase access to medication-assisted treatment (MAT) for rural veterans with opioid use disorder.
Offers evidence-based information, recommendations, guides, and tools for U.S. Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) healthcare providers and patients to assist in the decision making process to improve the treatment and outcomes for patients with substance use disorder (SUD), including opioid use disorder (OUD), methamphetamine use, and co-occurring mental health conditions. Describes best practices to help patients avoid preventable complications, reduce substance use, and improve their overall health and wellness.